 | • レポートコード：QAF27702 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のグルカゴン市場について種類別（グルカゴン注射、鼻グルカゴン）、用途別（緊急キット、一般使用、診断＆運動性、心原性ショック、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・グルカゴン市場の概要 ・世界の主要地域別グルカゴン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のグルカゴン市場規模2016-2021：種類別（グルカゴン注射、鼻グルカゴン） ・世界のグルカゴン市場予測2012-2027：種類別（グルカゴン注射、鼻グルカゴン） ・世界のグルカゴン市場規模2016-2021：用途別（緊急キット、一般使用、診断＆運動性、心原性ショック、その他） ・世界のグルカゴン市場予測2012-2027：用途別（緊急キット、一般使用、診断＆運動性、心原性ショック、その他） ・グルカゴンのアメリカ市場規模と予測2016-2021 ・グルカゴンのヨーロッパ市場規模と予測2016-2021 ・グルカゴンの中国市場規模と予測2016-2021 ・グルカゴンの日本市場規模と予測2016-2021 ・グルカゴンの東南アジア市場規模と予測2016-2021 ・グルカゴンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Eli Lilly、Fresenius Kabi、Torrent Labs、Taj Pharmaceuticals、Xeris Pharmaceuticals） ・グルカゴンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グルカゴンの市場動向・機会・課題 ・調査の結論 |
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Glucagon Market
The global Glucagon market was valued at US$ 556 in 2020 and will reach US$ 793.2 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Glucagon Scope and Market Size
The global Glucagon market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
The Glucagon market is analysed and market size information is provided by regions (countries). Segment by Application, the Glucagon market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
1 Glucagon Market Overview
1.1 Glucagon Product Scope
1.2 Glucagon Segment by Type
1.2.1 Global Glucagon Sales by Type (2016 & 2021 & 2027)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Segment by Application
1.3.1 Global Glucagon Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Glucagon Market Estimates and Forecasts (2016-2027)
1.4.1 Global Glucagon Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Glucagon Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Glucagon Price Trends (2016-2027)
2 Glucagon Estimates and Forecasts by Region
2.1 Global Glucagon Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Glucagon Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Glucagon Sales Market Share by Region (2016-2021)
2.2.2 Global Glucagon Revenue Market Share by Region (2016-2021)
2.3 Global Glucagon Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Glucagon Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Glucagon Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Glucagon Estimates and Projections (2016-2027)
2.4.2 Europe Glucagon Estimates and Projections (2016-2027)
2.4.3 China Glucagon Estimates and Projections (2016-2027)
2.4.4 Japan Glucagon Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Glucagon Estimates and Projections (2016-2027)
2.4.6 India Glucagon Estimates and Projections (2016-2027)
3 Global Glucagon Competition Landscape by Players
3.1 Global Top Glucagon Players by Sales (2016-2021)
3.2 Global Top Glucagon Players by Revenue (2016-2021)
3.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon as of 2020)
3.4 Global Glucagon Average Price by Company (2016-2021)
3.5 Manufacturers Glucagon Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Glucagon Market Size by Type
4.1 Global Glucagon Historic Market Review by Type (2016-2021)
4.1.1 Global Glucagon Sales Market Share by Type (2016-2021)
4.1.2 Global Glucagon Revenue Market Share by Type (2016-2021)
4.1.3 Global Glucagon Price by Type (2016-2021)
4.2 Global Glucagon Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Glucagon Sales Forecast by Type (2022-2027)
4.2.2 Global Glucagon Revenue Forecast by Type (2022-2027)
4.2.3 Global Glucagon Price Forecast by Type (2022-2027)
5 Global Glucagon Market Size by Application
5.1 Global Glucagon Historic Market Review by Application (2016-2021)
5.1.1 Global Glucagon Sales Market Share by Application (2016-2021)
5.1.2 Global Glucagon Revenue Market Share by Application (2016-2021)
5.1.3 Global Glucagon Price by Application (2016-2021)
5.2 Global Glucagon Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Glucagon Sales Forecast by Application (2022-2027)
5.2.2 Global Glucagon Revenue Forecast by Application (2022-2027)
5.2.3 Global Glucagon Price Forecast by Application (2022-2027)
6 North America Glucagon Market Facts & Figures
6.1 North America Glucagon Sales by Company
6.1.1 North America Glucagon Sales by Company (2016-2021)
6.1.2 North America Glucagon Revenue by Company (2016-2021)
6.2 North America Glucagon Sales Breakdown by Type
6.2.1 North America Glucagon Sales Breakdown by Type (2016-2021)
6.2.2 North America Glucagon Sales Breakdown by Type (2022-2027)
6.3 North America Glucagon Sales Breakdown by Application
6.3.1 North America Glucagon Sales Breakdown by Application (2016-2021)
6.3.2 North America Glucagon Sales Breakdown by Application (2022-2027)
7 Europe Glucagon Market Facts & Figures
7.1 Europe Glucagon Sales by Company
7.1.1 Europe Glucagon Sales by Company (2016-2021)
7.1.2 Europe Glucagon Revenue by Company (2016-2021)
7.2 Europe Glucagon Sales Breakdown by Type
7.2.1 Europe Glucagon Sales Breakdown by Type (2016-2021)
7.2.2 Europe Glucagon Sales Breakdown by Type (2022-2027)
7.3 Europe Glucagon Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Glucagon Market Facts & Figures
8.1 China Glucagon Sales by Company
8.1.1 China Glucagon Sales by Company (2016-2021)
8.1.2 China Glucagon Revenue by Company (2016-2021)
8.2 China Glucagon Sales Breakdown by Type
8.2.1 China Glucagon Sales Breakdown by Type (2016-2021)
8.2.2 China Glucagon Sales Breakdown by Type (2022-2027)
8.3 China Glucagon Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Glucagon Market Facts & Figures
9.1 Japan Glucagon Sales by Company
9.1.1 Japan Glucagon Sales by Company (2016-2021)
9.1.2 Japan Glucagon Revenue by Company (2016-2021)
9.2 Japan Glucagon Sales Breakdown by Type
9.2.1 Japan Glucagon Sales Breakdown by Type (2016-2021)
9.2.2 Japan Glucagon Sales Breakdown by Type (2022-2027)
9.3 Japan Glucagon Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Glucagon Market Facts & Figures
10.1 Southeast Asia Glucagon Sales by Company
10.1.1 Southeast Asia Glucagon Sales by Company (2016-2021)
10.1.2 Southeast Asia Glucagon Revenue by Company (2016-2021)
10.2 Southeast Asia Glucagon Sales Breakdown by Type
10.2.1 Southeast Asia Glucagon Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Glucagon Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Glucagon Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Glucagon Market Facts & Figures
11.1 India Glucagon Sales by Company
11.1.1 India Glucagon Sales by Company (2016-2021)
11.1.2 India Glucagon Revenue by Company (2016-2021)
11.2 India Glucagon Sales Breakdown by Type
11.2.1 India Glucagon Sales Breakdown by Type (2016-2021)
11.2.2 India Glucagon Sales Breakdown by Type (2022-2027)
11.3 India Glucagon Sales Breakdown by Application
11.3.1 India Glucagon Sales Breakdown by Application (2016-2021)
11.3.2 India Glucagon Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Glucagon Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Glucagon Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Glucagon Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Corporation Information
12.3.2 Fresenius Kabi Business Overview
12.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Fresenius Kabi Glucagon Products Offered
12.3.5 Fresenius Kabi Recent Development
12.4 Torrent Labs
12.4.1 Torrent Labs Corporation Information
12.4.2 Torrent Labs Business Overview
12.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Torrent Labs Glucagon Products Offered
12.4.5 Torrent Labs Recent Development
12.5 Taj Pharmaceuticals
12.5.1 Taj Pharmaceuticals Corporation Information
12.5.2 Taj Pharmaceuticals Business Overview
12.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Taj Pharmaceuticals Glucagon Products Offered
12.5.5 Taj Pharmaceuticals Recent Development
12.6 Xeris Pharmaceuticals
12.6.1 Xeris Pharmaceuticals Corporation Information
12.6.2 Xeris Pharmaceuticals Business Overview
12.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Xeris Pharmaceuticals Glucagon Products Offered
12.6.5 Xeris Pharmaceuticals Recent Development
…
13 Glucagon Manufacturing Cost Analysis
13.1 Glucagon Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon
13.4 Glucagon Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon Distributors List
14.3 Glucagon Customers
15 Market Dynamics
15.1 Glucagon Market Trends
15.2 Glucagon Drivers
15.3 Glucagon Market Challenges
15.4 Glucagon Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glucagon Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Glucagon Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Glucagon Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Glucagon Sales (K MT) by Region (2016-2021)
Table 5. Global Glucagon Sales Market Share by Region (2016-2021)
Table 6. Global Glucagon Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Glucagon Revenue Share by Region (2016-2021)
Table 8. Global Glucagon Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Glucagon Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Glucagon Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Glucagon Revenue Share Forecast by Region (2022-2027)
Table 12. Global Glucagon Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Glucagon Sales Share by Company (2016-2021)
Table 14. Global Glucagon Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Glucagon Revenue Share by Company (2016-2021)
Table 16. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2020)
Table 17. Global Glucagon Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Glucagon Manufacturing Sites and Area Served
Table 19. Manufacturers Glucagon Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Glucagon Sales (K MT) by Type (2016-2021)
Table 22. Global Glucagon Sales Share by Type (2016-2021)
Table 23. Global Glucagon Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Glucagon Price (USD/MT) by Type (2016-2021)
Table 25. Global Glucagon Sales Share by Type (2022-2027)
Table 26. Global Glucagon Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Glucagon Revenue Share by Type (2022-2027)
Table 28. Global Glucagon Price (USD/MT) by Type (2022-2027)
Table 29. Global Glucagon Sales (K MT) by Application (2016-2021)
Table 30. Global Glucagon Sales Share by Application (2016-2021)
Table 31. Global Glucagon Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Glucagon Price (USD/MT) by Application (2016-2021)
Table 33. Global Glucagon Sales (K MT) by Application (2022-2027)
Table 34. Global Glucagon Sales Share by Application (2022-2027)
Table 35. Global Glucagon Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Glucagon Revenue Share by Application (2022-2027)
Table 37. Global Glucagon Price (USD/MT) by Application (2022-2027)
Table 38. North America Glucagon Sales (K MT) by Company (2016-2021)
Table 39. North America Glucagon Sales Market Share by Company (2016-2021)
Table 40. North America Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Glucagon Revenue Market Share by Company (2016-2021)
Table 42. North America Glucagon Sales by Type (2016-2021) & (K MT)
Table 43. North America Glucagon Sales Market Share by Type (2016-2021)
Table 44. North America Glucagon Sales by Type (2022-2027) & (K MT)
Table 45. North America Glucagon Sales Market Share by Type (2022-2027)
Table 46. North America Glucagon Sales by Application (2016-2021) & (K MT)
Table 47. North America Glucagon Sales Market Share by Application (2016-2021)
Table 48. North America Glucagon Sales by Application (2022-2027) & (K MT)
Table 49. North America Glucagon Sales Market Share by Application (2022-2027)
Table 50. Europe Glucagon Sales (K MT) by Company (2016-2021)
Table 51. Europe Glucagon Sales Market Share by Company (2016-2021)
Table 52. Europe Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Glucagon Revenue Market Share by Company (2016-2021)
Table 54. Europe Glucagon Sales by Type (2016-2021) & (K MT)
Table 55. Europe Glucagon Sales Market Share by Type (2016-2021)
Table 56. Europe Glucagon Sales by Type (2022-2027) & (K MT)
Table 57. Europe Glucagon Sales Market Share by Type (2022-2027)
Table 58. Europe Glucagon Sales by Application (2016-2021) & (K MT)
Table 59. Europe Glucagon Sales Market Share by Application (2016-2021)
Table 60. Europe Glucagon Sales by Application (2022-2027) & (K MT)
Table 61. Europe Glucagon Sales Market Share by Application (2022-2027)
Table 62. China Glucagon Sales (K MT) by Company (2016-2021)
Table 63. China Glucagon Sales Market Share by Company (2016-2021)
Table 64. China Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Glucagon Revenue Market Share by Company (2016-2021)
Table 66. China Glucagon Sales by Type (2016-2021) & (K MT)
Table 67. China Glucagon Sales Market Share by Type (2016-2021)
Table 68. China Glucagon Sales by Type (2022-2027) & (K MT)
Table 69. China Glucagon Sales Market Share by Type (2022-2027)
Table 70. China Glucagon Sales by Application (2016-2021) & (K MT)
Table 71. China Glucagon Sales Market Share by Application (2016-2021)
Table 72. China Glucagon Sales by Application (2022-2027) & (K MT)
Table 73. China Glucagon Sales Market Share by Application (2022-2027)
Table 74. Japan Glucagon Sales (K MT) by Company (2016-2021)
Table 75. Japan Glucagon Sales Market Share by Company (2016-2021)
Table 76. Japan Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Glucagon Revenue Market Share by Company (2016-2021)
Table 78. Japan Glucagon Sales by Type (2016-2021) & (K MT)
Table 79. Japan Glucagon Sales Market Share by Type (2016-2021)
Table 80. Japan Glucagon Sales by Type (2022-2027) & (K MT)
Table 81. Japan Glucagon Sales Market Share by Type (2022-2027)
Table 82. Japan Glucagon Sales by Application (2016-2021) & (K MT)
Table 83. Japan Glucagon Sales Market Share by Application (2016-2021)
Table 84. Japan Glucagon Sales by Application (2022-2027) & (K MT)
Table 85. Japan Glucagon Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Glucagon Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Glucagon Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Glucagon Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Glucagon Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Glucagon Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Glucagon Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Glucagon Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Glucagon Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Glucagon Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Glucagon Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Glucagon Sales Market Share by Application (2022-2027)
Table 98. India Glucagon Sales (K MT) by Company (2016-2021)
Table 99. India Glucagon Sales Market Share by Company (2016-2021)
Table 100. India Glucagon Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Glucagon Revenue Market Share by Company (2016-2021)
Table 102. India Glucagon Sales by Type (2016-2021) & (K MT)
Table 103. India Glucagon Sales Market Share by Type (2016-2021)
Table 104. India Glucagon Sales by Type (2022-2027) & (K MT)
Table 105. India Glucagon Sales Market Share by Type (2022-2027)
Table 106. India Glucagon Sales by Application (2016-2021) & (K MT)
Table 107. India Glucagon Sales Market Share by Application (2016-2021)
Table 108. India Glucagon Sales by Application (2022-2027) & (K MT)
Table 109. India Glucagon Sales Market Share by Application (2022-2027)
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Novo Nordisk Glucagon Product
Table 114. Novo Nordisk Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Eli Lilly Glucagon Product
Table 119. Eli Lilly Recent Development
Table 120. Fresenius Kabi Corporation Information
Table 121. Fresenius Kabi Description and Business Overview
Table 122. Fresenius Kabi Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Fresenius Kabi Glucagon Product
Table 124. Fresenius Kabi Recent Development
Table 125. Torrent Labs Corporation Information
Table 126. Torrent Labs Description and Business Overview
Table 127. Torrent Labs Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Torrent Labs Glucagon Product
Table 129. Torrent Labs Recent Development
Table 130. Taj Pharmaceuticals Corporation Information
Table 131. Taj Pharmaceuticals Description and Business Overview
Table 132. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Taj Pharmaceuticals Glucagon Product
Table 134. Taj Pharmaceuticals Recent Development
Table 135. Xeris Pharmaceuticals Corporation Information
Table 136. Xeris Pharmaceuticals Description and Business Overview
Table 137. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Xeris Pharmaceuticals Glucagon Product
Table 139. Xeris Pharmaceuticals Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Glucagon Distributors List
Table 143. Glucagon Customers List
Table 144. Glucagon Market Trends
Table 145. Glucagon Market Drivers
Table 146. Glucagon Market Challenges
Table 147. Glucagon Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Product Picture
Figure 2. Global Glucagon Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glucagon Sales Market Share by Application in 2021 & 2027
Figure 6. Emergency Kits Examples
Figure 7. General Use Examples
Figure 8. Diagnostic & Motility Examples
Figure 9. Cardiogenic Shock Examples
Figure 10. Others Examples
Figure 11. Global Glucagon Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Glucagon Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Glucagon Sales (K MT) Growth Rate (2016-2027)
Figure 14. Global Glucagon Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 15. Global Glucagon Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Glucagon Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Glucagon Sales (K MT) Growth Rate (2016-2027)
Figure 19. Europe Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Glucagon Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Glucagon Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Glucagon Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Glucagon Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Glucagon Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Glucagon Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Glucagon Players Market Share by Revenue in Glucagon: 2016 & 2020
Figure 30. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Glucagon Revenue Share by Type (2016-2021)
Figure 32. Global Glucagon Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Glucagon Revenue Share by Application (2016-2021)
Figure 34. Global Glucagon Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Glucagon Sales Market Share by Type in 2020
Figure 36. North America Glucagon Sales Market Share by Application in 2020
Figure 37. Europe Glucagon Sales Market Share by Type in 2020
Figure 38. Europe Glucagon Sales Market Share by Application in 2020
Figure 39. China Glucagon Sales Market Share by Type in 2020
Figure 40. China Glucagon Sales Market Share by Application in 2020
Figure 41. Japan Glucagon Sales Market Share by Type in 2020
Figure 42. Japan Glucagon Sales Market Share by Application in 2020
Figure 43. Southeast Asia Glucagon Sales Market Share by Type in 2020
Figure 44. Southeast Asia Glucagon Sales Market Share by Application in 2020
Figure 45. India Glucagon Sales Market Share by Type in 2020
Figure 46. India Glucagon Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Glucagon
Figure 49. Manufacturing Process Analysis of Glucagon
Figure 50. Glucagon Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
世界のグルカゴン様ペプチド-1受容体アゴニスト市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glucagon-like Peptide-1 Receptor Agonist Market The global Glucagon-like Peptide-1 Receptor Agonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- グルカゴン様ペプチド-1（GLP-1）刺激薬のグローバル市場2021 Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Un…
- グルカゴン様ペプチド2受容体のグローバル市場調査 2019年 The global Glucagon Like Peptide 2 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glucagon Like Peptide 2 Receptor volume and value at global level, regional level and company level. From …
- バイオシミラーのグローバル市場調査 2019年 The global Biosimilars market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represen…
- 世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Congenital Hyperinsulinism Treatment Drugs Market The global Congenital Hyperinsulinism Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…